MEDIUM confidence: 100% data completeness, but the composite (57) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $7.8B— | $8.4B+6.9% | $9.7B+15.7% | $10.4B+7.3% | $11.2B+7.5% |
| EPS (dil.) | $2.96— | $3.46+16.9% | $4.54+31.2% | $6.04+33.0% | $6.83+13.1% |
| Free Cash Flow | $943M— | $889M-5.7% | $1.0B+14.2% | $1.6B+60.3% | $1.5B-7.9% |
| Gross Margin | 30.3% | 30.4%+0.1pp | 30.4%+0.0pp | 32.4%+2.0pp | 31.5%-0.9pp |
| Operating Margin | 11.2% | 12.1%+0.9pp | 13.1%+1.0pp | 15.5%+2.4pp | 16.7%+1.2pp |
| Net Margin | 7.1% | 7.6%+0.4pp | 8.4%+0.9pp | 10.2%+1.7pp | 10.5%+0.3pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 8.7%/yr (revenue basis).
Base free cash flow $1.4B (avg FY2023–FY2025; latest year $1.5B) · equity value $47.2B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Buy-rated share 83% → 83% over ~3 months (+0pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Oct 2026 | $2.73 | $2.83 | +3.7% |
| Jul 2026 | $2.60 | $2.76 | +6.2% |
| Apr 2026 | $2.51 | $2.71 | +8.0% |
| Feb 2026 | $2.08 | $2.10 | +1.0% |
| Oct 2025 | $2.28 | $2.32 | +1.8% |
| Jul 2025 | $2.17 | $1.96 | -9.7% |
| Apr 2025 | $2.03 | $2.28 | +12.3% |
| Feb 2025 | $1.74 | $1.68 | -3.4% |
Net insider -$10.2M over 180 days (0 open-market buys, 65 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
The QScore of 57 for WAB indicates a neutral outlook, driven by a mix of factors. The stock scores high on risk, with a relatively low beta and moderate volatility, but is held back by mediocre value and profitability scores, due in part to a P/E of 34.6 and ROE of 12.2%. Momentum is a positive factor, with a 12-month return of 38.7%, although this is somewhat offset by a recent 3-month decline of 5.7%. The long-term and short-term scores are relatively aligned, suggesting a consistent outlook.